Please wait a minute...
浙江大学学报(医学版)  2019, Vol. 48 Issue (4): 367-372    DOI: 10.3785/j.issn.1008-9292.2019.08.03
专题报道     
Ⅰ型神经纤维瘤一家系的基因检测及产前诊断
刘蓓(),杨艳梅,严恺,陈敏,王丽雅,黄颖之,钱叶青,董旻岳*()
浙江大学医学院附属妇产科医院生殖遗传科 生殖遗传教育部重点实验室, 浙江 杭州 310006
Genetic analysis and prenatal diagnosis of a sporadic family with neurofibromatosis type 1
LIU Bei(),YANG Yanmei,YAN Kai,CHEN Min,WANG Liya,HUANG Yingzhi,QIAN Yeqing,DONG Minyue*()
Key Laboratory of Reproductive Genetics, Ministry of Education, Department of Reproductive Genetics, Women's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China
 全文: PDF(1079 KB)   HTML( 17 )
摘要:

目的: 对一个Ⅰ型神经纤维瘤家系进行遗传学病因分析及产前诊断。方法: 应用目标捕获高通量测序和Sanger测序技术,对一个散发的Ⅰ型神经纤维瘤家系进行基因突变分析。提取先证者及其父母外周血淋巴细胞RNA,行RT-PCR及扩增产物测序分析。明确突变致病性后,抽取羊水标本对胎儿行产前基因诊断。结果: 先证者NF1基因存在c.1260+4A>T杂合剪接突变,为新发突变。RNA剪接分析提示先证者NF1基因发生转录时,11号外显子3'端发生相邻内含子区13个碱基的插入,理论上可导致蛋白编码提前终止,产生截短蛋白,影响蛋白功能。产前基因检测结果显示胎儿未携带该突变。结论: NF1:c.1260+4A>T杂合剪接突变是该Ⅰ型神经纤维瘤患者的致病原因,本研究结果为该家系遗传咨询和产前诊断提供了理论依据。

关键词: 神经纤维瘤/遗传学基因, 神经纤维瘤病1型羊水产前诊断基因检测系谱突变外显子聚合酶链反应    
Abstract:

Objective: To identify pathogenic mutation for a family with neurofibromatosis type 1(NF1) and provide prenatal diagnosis for them. Methods: Mutation analysis of the sporadic family with NF1 was performed with target captured next generation sequencing and Sanger sequencing. RNA samples were extracted from the lymphocytes of NF1 patient and her parents. RT-PCR and Sanger sequencing were performed to analyze the relative mRNA expression in the samples. Prenatal diagnosis of the pathogenic mutation was offered to the fetus. Results: A novel splicing mutation c.1260+4A>T in the NF1 gene was found in the proband of the family, but was not found in her parents.cDNA sequencing showed that 13 bases inserted into the 3' end of exon 11 in the NF1 gene lead to a frameshift mutation. Prenatal diagnosis suggested that the fetus did not carried the mutant. Conclusion: The NF1: c.1260+4A>T mutation found in the NF1 patient is considered to be pathogenic, which provides information for family genetic counseling and prenatal diagnosis.

Key words: Neurofibroma/genetics    Genes, neurofibromatosis 1    Amniotic fluid    Prenatal diagnosis    Genetic testing    Pedigree    Mutation    Exons    Polymerase chain reaction
收稿日期: 2019-03-28 出版日期: 2019-10-30
:  R394.3  
基金资助: 浙江省重点研发计划(2019C03025);浙江省自然科学基金(LQ19H090019);浙江省医药卫生科技计划(2018PY022)
通讯作者: 董旻岳     E-mail: liubei@zju.edu.cn;dongmy@zju.edu.cn
作者简介: 刘蓓(1987—), 女, 硕士, 主管技师, 主要从事单基因遗传病的基因检测与产前诊断研究; E-mail: liubei@zju.edu.cn; https://orcid.org/0000-0002-8687-2277
服务  
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章  
刘蓓
杨艳梅
严恺
陈敏
王丽雅
黄颖之
钱叶青
董旻岳

引用本文:

刘蓓,杨艳梅,严恺,陈敏,王丽雅,黄颖之,钱叶青,董旻岳. Ⅰ型神经纤维瘤一家系的基因检测及产前诊断[J]. 浙江大学学报(医学版), 2019, 48(4): 367-372.

LIU Bei,YANG Yanmei,YAN Kai,CHEN Min,WANG Liya,HUANG Yingzhi,QIAN Yeqing,DONG Minyue. Genetic analysis and prenatal diagnosis of a sporadic family with neurofibromatosis type 1. J Zhejiang Univ (Med Sci), 2019, 48(4): 367-372.

链接本文:

http://www.zjujournals.com/med/CN/10.3785/j.issn.1008-9292.2019.08.03        http://www.zjujournals.com/med/CN/Y2019/V48/I4/367

图 1  本组Ⅰ型神经纤维瘤家系 NF1 基因测序结果
图 2  本组Ⅰ型神经纤维瘤家系cDNA测序结果和剪接分析
1 XU W , YANG X , HU X et al. Fifty-four novel mutations in the NF1 gene and integrated analyses of the mutations that modulate splicing[J]. Int J Mol Med, 2014, 34 (1): 53- 60
doi: 10.3892/ijmm.2014.1756
2 KEHRER-SAWATZKI H , MAUTNER V F , COOPERD N . Emerging genotype-phenotype relation-ships in patients with large NF1 deletions[J]. Hum Genet, 2017, 136 (4): 349- 376
doi: 10.1007/s00439-017-1766-y
3 HINMAN M N , SHARMA A , LUO G et al. Neurofibromatosis type 1 alternative splicing is a key regulator of Ras signaling in neurons[J]. Mol Cell Biol, 2014, 34 (12): 2188- 2197
doi: 10.1128/MCB.00019-14
4 CUI Y , MORRISON H . Construction of cloning-friendly minigenes for mammalian expression of full-length human NF1 isoforms[J]. Hum Mutat, 2019, 40 (2): 187- 192
doi: 10.1002/humu.23681
5 PELTONEN S , KALLIONP?? R A , PELTONEN J . Neurofibromatosis type 1(NF1) gene:Beyond café au lait spots and dermal neurofibromas[J]. Exp Dermatol, 2017, 26 (7): 645- 648
doi: 10.1111/exd.13212
6 BANERJEE S , LEI D , LIANG S et al. Novel phenotypes of NF1 patients from unrelated Chinese families with tibial pseudarthrosis and anemia[J]. Oncotarget, 2017, 8 (24): 39695- 39702
7 GUTMANN D H , FERNER R E , LISTERNICKR H et al. Neurofibromatosis type 1[J]. Nat Rev Dis Primers, 2017, 3:17004
doi: 10.1038/nrdp.2017.4
8 LISTED N A . Nationalinstitutes of health consensus development conference statement on neurofibromatosis[J]. Arch Neurol, 1988, 45:575- 578
doi: 10.1001/archneur.1988.00520290115023
9 RICHARDS S , AZIZ N , BALE S et al. Standards and guidelines for the interpretation of sequence variants:a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17 (5): 405- 424
doi: 10.1038/gim.2015.30
10 JETT K , FRIEDMAN J M . Clinical and genetic aspects of neurofibromatosis 1[J]. Genet Med, 2010, 12 (1): 1- 11
doi: 10.1097/GIM.0b013e3181bf15e3
11 TSIPI M , POULOU M , FYLAKTOU I et al. Phenotypic expression of a spectrum of neurofibromatosis type 1(NF1) mutations identified through NGS and MLPA[J]. J Neurol Sci, 2018, 395:95- 105
doi: 10.1016/j.jns.2018.10.006
12 PALMA MILLA C , LEZANA ROSALES J M , LóPEZ MONTIEL J et al. Neurofibromatosis type Ⅰ:mutation spectrum of NF1 in spanish patients[J]. Ann Hum Genet, 2018, 82 (6): 425- 436
doi: 10.1111/ahg.12272
13 KOCZKOWSKA M , CHEN Y , CALLENS T et al. Genotype-phenotype correlation in NF1:evidence for a more severe phenotype associated with missense mutations affecting NF1 codons 844-848[J]. Am J Hum Genet, 2018, 102 (1): 69- 87
14 UPADHYAYA M , KLUWE L , SPURLOCK G et al. Germline and somatic NF1 gene mutation spectrum in NF1-associated malignant peripheral nerve sheath tumors (MPNSTs)[J]. Hum Mutat, 2008, 29 (1): 74- 82
15 PROS E , GóMEZ C , MARTíN T et al. Nature and mRNA effect of 282 different NF1 point mutations:focus on splicing alterations[J]. Hum Mutat, 2008, 29 (9): E173- E193
doi: 10.1002/humu.20826
[1] 张丹丹,王军梅. 胎儿肝血管瘤的产前影像学诊断和管理[J]. 浙江大学学报(医学版), 2019, 48(4): 439-445.
[2] 楼铁,黄颖之,董旻岳. CLN6基因复合杂合突变导致神经元蜡样脂褐质沉积症一家系遗传学研究[J]. 浙江大学学报(医学版), 2019, 48(4): 373-377.
[3] 许雨晴,钱叶青,姚维妙,董旻岳. Van der Woude综合征一家系遗传学分析[J]. 浙江大学学报(医学版), 2019, 48(4): 378-383.
[4] 叶青,张莹莹,王晶晶,毛建华. Ⅳ型胶原α5链基因突变致奥尔波特综合征两家系遗传学分析[J]. 浙江大学学报(医学版), 2019, 48(4): 384-389.
[5] 殷一旋,朱晖,钱叶青,金晶磊,梅瑾,董旻岳. 2057名双胎妊娠孕妇无创产前筛查结果分析[J]. 浙江大学学报(医学版), 2019, 48(4): 403-408.
[6] 雷雨,董旻岳. 孕妇年龄影响胎儿性染色体非整倍体风险[J]. 浙江大学学报(医学版), 2019, 48(4): 409-413.
[7] 罗玉琴,沈敏,孙义锡,钱叶青,王丽雅,俞佳玲,胡珺洁,金帆,董旻岳. 一例染色体复杂易位致胎儿多发畸形的遗传学诊断[J]. 浙江大学学报(医学版), 2019, 48(4): 397-402.
[8] 梅瑾,刘姣,王敏,张闻,王昊,卢莎,何茶英,靳春雷. 八例22q11.2区微重复胎儿产前诊断和妊娠结局分析[J]. 浙江大学学报(医学版), 2019, 48(4): 429-433.
[9] 洪萍萍,郭冰洁,林莉,林细华,周嘉强. 葡萄糖激酶W257R突变致青少年发病的成人型糖尿病一家系分析[J]. 浙江大学学报(医学版), 2019, 48(2): 200-203.
[10] 杜东芬,朱丽霞,王云贵,叶琇锦. 肾母细胞瘤1基因表达及其对急性髓系白血病患者预后的预测价值[J]. 浙江大学学报(医学版), 2019, 48(1): 50-57.
[11] 唐思阳,叶佳,李月舟. I1363T突变致人骨骼肌电压门控钠通道快失活受损的机制[J]. 浙江大学学报(医学版), 2019, 48(1): 12-18.
[12] 尹黎,李歌,沈健,刘震杰. 遗传性易栓症筛查及相关基因检测分析[J]. 浙江大学学报(医学版), 2018, 47(6): 606-611.
[13] 翁炳焕,徐威,苏岚,沈敏,李蓉,虞晓鹏,李兰娟. 脂质体介导SV40LT基因转染构建羊水染色体核型分析质控细胞系研究[J]. 浙江大学学报(医学版), 2018, 47(5): 520-524.
[14] 史庭,叶琇锦. CCAAT增强子结合蛋白α与急性髓细胞白血病的发生[J]. 浙江大学学报(医学版), 2018, 47(5): 552-557.
[15] 王佳静,谷海瀛. 幽门螺杆菌的基因分型技术及其应用[J]. 浙江大学学报(医学版), 2018, 47(1): 97-103.